Molina director receives 237-share equity grant

ORLANDO STEVEN J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

ORLANDO STEVEN J reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare director Steven J. Orlando, through the Orlando Family Trust, received a grant of 237 shares of common stock on July 1, 2026 under the company’s 2025 Equity Incentive Plan. The grant represents a quarterly equity award valued at $55,000, based on the $232.55 closing share price, as part of a $220,000 annual director equity package. Following this award, the trust holds 17,967 shares, and an additional 1,500 shares are held indirectly through Orlando’s 401(k) plan.

Insider Trade Summary

Grant/Award: 237 shares

Grant/Award 2 txns

Insider ORLANDO STEVEN J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	237	$232.55	$55K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 17,967 shares (Indirect, Held by trust); Common Stock — 1,500 shares (Indirect, Held by reporting person's 401(k) plan.)

Footnotes (4)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.
3. F3. Represents the closing price of the Issuer's common stock on July 1, 2026.
4. F4. Shares are held by Orlando Family Trust.

Key Figures

Director equity grant: 237 shares Grant valuation per quarter: $55,000 Annual director equity award: $220,000 +3 more

6 metrics

Director equity grant 237 shares Common stock granted July 1, 2026 under 2025 Equity Incentive Plan

Grant valuation per quarter $55,000 Quarterly portion of director annual equity award

Annual director equity award $220,000 Total yearly equity value for each director

Grant pricing reference $232.55 per share Closing price on July 1, 2026 used to size award

Trust holdings after grant 17,967 shares Shares of common stock held by Orlando Family Trust after transaction

401(k) plan holdings 1,500 shares Common stock held by reporting person’s 401(k) plan

Key Terms

2025 Equity Incentive Plan, annual equity award, Orlando Family Trust, 401(k) plan

4 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted..."

Orlando Family Trust financial

"Shares are held by Orlando Family Trust."

401(k) plan financial

"Held by reporting person's 401(k) plan."

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Molina Healthcare (MOH) director Steven J. Orlando report in this Form 4?

Steven J. Orlando reported receiving 237 shares of Molina Healthcare common stock as a director equity grant. The shares were issued to the Orlando Family Trust under the 2025 Equity Incentive Plan, reflecting routine, compensation-related stock rather than an open-market purchase or sale.

How was the size of Steven J. Orlando’s Molina Healthcare (MOH) stock grant determined?

The grant size was based on a quarterly equity value of $55,000 for directors. On July 1, 2026, Molina Healthcare’s closing share price was $232.55, so dividing $55,000 by $232.55 resulted in a grant of 237 shares to the Orlando Family Trust.

What is the total annual equity award for Molina Healthcare (MOH) directors?

The total annual equity award for each Molina Healthcare director is set at $220,000. This amount is delivered in four quarterly grants of $55,000 each, with the number of shares per grant based on the company’s closing stock price on the grant date.

How many Molina Healthcare (MOH) shares does the Orlando Family Trust hold after this transaction?

After the July 1, 2026 grant, the Orlando Family Trust holds 17,967 shares of Molina Healthcare common stock. These shares are reported as indirectly owned by director Steven J. Orlando, separate from shares held in his 401(k) plan.

Does Steven J. Orlando hold Molina Healthcare (MOH) shares through a retirement plan?

Yes. In addition to trust holdings, 1,500 Molina Healthcare common shares are held by Steven J. Orlando’s 401(k) plan. These are reported as indirect ownership, reflecting retirement-plan holdings distinct from the Orlando Family Trust’s equity award position.

Is the reported Molina Healthcare (MOH) stock transaction an open-market trade?

No. The reported transaction is a grant or award of 237 shares under Molina Healthcare’s 2025 Equity Incentive Plan. It is compensation-related, tied to director service, and not an open-market purchase or sale of shares by Steven J. Orlando.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ORLANDO STEVEN J

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A(1)		237(2)	A	$232.55(3)	17,967	I	Held by trust(4)
Common Stock								1,500	I	Held by reporting person's 401(k) plan.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2026 was $232.55, which resulted in a grant of 237 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2026.

4. Shares are held by Orlando Family Trust.

Remarks:

	Jeff. D. Barlow, by power of attorney for Steven J. Orlando.	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)